Neurotech International Ltd (NTI) - Total Liabilities

Latest as of December 2025: AU$932.85K AUD ≈ $660.05K USD

Based on the latest financial reports, Neurotech International Ltd (NTI) has total liabilities worth AU$932.85K AUD (≈ $660.05K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore NTI cash flow conversion to assess how effectively this company generates cash.

Neurotech International Ltd - Total Liabilities Trend (2015–2025)

This chart illustrates how Neurotech International Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Neurotech International Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.

Neurotech International Ltd Competitors by Total Liabilities

The table below lists competitors of Neurotech International Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Weha Transportasi Indonesia TBK JK:WEHA	Indonesia	Rp137.49 Billion
Ruffer Investment Company Limited LSE:RICA	UK	GBX5.74 Million
Hoth Therapeutics Inc NASDAQ:HOTH	USA	$1.01 Million
Mitra Pemuda Tbk PT JK:MTRA	Indonesia	Rp207.00 Billion
B.A.G Films and Media Limited NSE:BAGFILMS	India	Rs1.95 Billion
Standard Industries Limited NSE:SIL	India	Rs441.07 Million
Garibaldi Resources Corp. V:GGI	Canada	CA$3.07 Million
Great Northern Minerals Ltd AU:GNM	Australia	AU$139.85K

Liability Composition Analysis (2015–2025)

This chart breaks down Neurotech International Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see NTI company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	7.30	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.16	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.14	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Neurotech International Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Neurotech International Ltd (2015–2025)

The table below shows the annual total liabilities of Neurotech International Ltd from 2015 to 2025.

Year	Total Liabilities	Change
2025-06-30	AU$285.74K ≈ $202.18K	-9.20%
2024-06-30	AU$314.70K ≈ $222.67K	-76.63%
2023-06-30	AU$1.35 Million ≈ $952.99K	+127.14%
2022-06-30	AU$592.98K ≈ $419.57K	-48.19%
2021-06-30	AU$1.14 Million ≈ $809.75K	+57.40%
2020-06-30	AU$727.10K ≈ $514.47K	+104.62%
2019-06-30	AU$355.33K ≈ $251.42K	-5.41%
2018-06-30	AU$375.66K ≈ $265.80K	-42.83%
2017-06-30	AU$657.04K ≈ $464.90K	-26.43%
2016-06-30	AU$893.12K ≈ $631.94K	-55.08%
2015-12-31	AU$1.99 Million ≈ $1.41 Million	--

About Neurotech International Ltd

AU:NTI Australia Biotechnology

Market Cap

$11.01 Million

AU$15.56 Million AUD

Market Cap Rank

#26629 Global

#1305 in Australia

Share Price

AU$0.01

Change (1 day)

+0.00%

52-Week Range

AU$0.01 - AU$0.03

All Time High

AU$0.48